710 Proton Pump Inhibitor Use but Not Statin Use Is Associated With Decreased Risk for High-grade Dysplasia and Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Results From a Large, Multicenter Cohort Study

Proton Pump ◽

Barrett's Esophagus ◽

High Grade Dysplasia ◽

High Grade ◽

Multicenter Cohort ◽

Statin Use

M1104 Predicting High-Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(10)61530-2 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-333 ◽

Cited By ~ 2

Author(s):

Srinivas Gaddam ◽

Patrick E. Young ◽

Amy Wang ◽

Ajay Bansal ◽

Neil Gupta ◽

...

Keyword(s):

Cohort Study ◽

Barrett’S Esophagus ◽

Barrett's Esophagus ◽

High Grade Dysplasia ◽

High Grade ◽

Multicenter Cohort

Su1108 Major Complications During Endoscopic Eradication Therapy (EET) for Barrett's Esophagus (BE) With High Grade Dysplasia (HGD) and Early Cancer (EC): Results From a Large Multicenter Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(12)61607-2 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-426-S-427

Author(s):

Sachin Wani ◽

Neil Gupta ◽

Brian C. Brauer ◽

Gokulakrishnan Balasubramanian ◽

Srinivas Gaddam ◽

...

Keyword(s):

Cohort Study ◽

Barrett’S Esophagus ◽

Barrett's Esophagus ◽

Early Cancer ◽

Eradication Therapy ◽

High Grade Dysplasia ◽

High Grade ◽

Multicenter Cohort ◽

Major Complications

Relationship Between Barrett's Esophagus (BE) Length and the Risk of High Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non Dysplastic Barrett's Esophagus Results From a Large Multicenter Cohort

Gastroenterology ◽

10.1016/s0016-5085(11)60329-6 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-81 ◽

Cited By ~ 4

Author(s):

Srinivas Gaddam ◽

Patrick E. Young ◽

Benjamin R. Alsop ◽

Neil Gupta ◽

Hemanth Gavini ◽

...

Keyword(s):

Barrett’S Esophagus ◽

Barrett's Esophagus ◽

High Grade Dysplasia ◽

High Grade ◽

Multicenter Cohort

Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma: A Large Retrospective Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(17)31725-0 ◽

2017 ◽

Vol 152 (5) ◽

pp. S455

Author(s):

Swetha Kambhampati ◽

Brandon Luber ◽

Hao Wang ◽

Stephen J. Meltzer

Keyword(s):

Risk Factors ◽

Cohort Study ◽

Barrett’S Esophagus ◽

Retrospective Cohort Study ◽

Barrett's Esophagus ◽

Retrospective Cohort ◽

High Grade Dysplasia ◽

461 PROTON PUMP INHIBITOR AND STATIN USE DECREASE RISK OF ESOPHAGEAL ADENOCARCINOMA AMONG INDIVIDUALS WITH BARRETT'S ESOPHAGUS: A SEER-MEDICARE ANALYSIS

Gastroenterology ◽

10.1016/s0016-5085(20)30897-0 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-87-S-88

Author(s):

Holli A. Loomans-Kropp ◽

Matthew Chaloux ◽

Ellen Richmond ◽

Asad Umar

Keyword(s):

Proton Pump Inhibitor ◽

Barrett’S Esophagus ◽

Proton Pump ◽

Barrett's Esophagus ◽

Statin Use

Commentary on: Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03667-7 ◽

2021 ◽

Author(s):

Jia Li ◽

Yuwei Fan

Keyword(s):

Barrett’S Esophagus ◽

Proton Pump Inhibitors ◽

Proton Pump ◽

Barrett's Esophagus ◽

Meta Analysis ◽

High Grade Dysplasia ◽

Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03544-3 ◽

2021 ◽

Author(s):

Yue Chen ◽

Chenyu Sun ◽

Yile Wu ◽

Xin Chen ◽

Sujatha Kailas ◽

...

Keyword(s):

Barrett’S Esophagus ◽

Proton Pump Inhibitors ◽

Proton Pump ◽

Barrett's Esophagus ◽

Meta Analysis ◽

High Grade Dysplasia ◽

Is the Extent of Low-Grade Dysplasia (LGD) in Barrett's Esophagus (BE) a Risk Factor for the Development of Esophageal Adenocarcinoma (EAC): Results From a Large, Multicenter Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(11)60877-9 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-217

Author(s):

Sachin B. Wani ◽

David A. Lieberman ◽

Hemanth Gavini ◽

Neil Gupta ◽

Lisa Yerian ◽

...

Keyword(s):

Risk Factor ◽

Cohort Study ◽

Barrett’S Esophagus ◽

Barrett's Esophagus ◽

Low Grade ◽

Multicenter Cohort ◽

Low Grade Dysplasia

Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett’s esophagus: a systematic review and meta-analysis

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2022.2008909 ◽

2021 ◽

Author(s):

Haijuan Yao ◽

Le Wang ◽

Hongyu Li ◽

Shixue Xu ◽

Zhaohui Bai ◽

...

Keyword(s):

Systematic Review ◽

Barrett’S Esophagus ◽

Proton Pump Inhibitors ◽

Proton Pump ◽

Barrett's Esophagus ◽

Meta Analysis ◽

High Grade Dysplasia ◽

475c Low Risk of Developing Dysplasia and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter, Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(10)60286-7 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-63 ◽

Cited By ~ 3

Author(s):

Sachin B. Wani ◽

Gary W. Falk ◽

Matthew Hall ◽

Amy Wang ◽

Neil Gupta ◽

...

Keyword(s):

Cohort Study ◽

Barrett’S Esophagus ◽

Barrett's Esophagus ◽

Low Risk ◽

Multicenter Cohort